(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CORVISION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CORVISION

ST13

US500000079286492

Class

5, 10

Filing

79286492

Registration

6495490

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

03/07/2025

Trademark type

Word

Nice classes

5, 10

Filing date

01/31/2020

Registration date

09/28/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/28/2021

Last transaction

03/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

64

Owner location

SE

Examiner

BILLINGS, JOHN

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

LinkoCare Life Sciences AB

Representatives

R Peter Spies DTL Limited

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Collagen for medical use; biological implantsbiological eye tissue intended for subsequent implantationbiological skin tissue intended for subsequent implantationbiological cardiac tissue intended for subsequent implantationbiological tissue grafts; biological cornealcardiacnerveskin tissue for implantation; surgical implants comprised of living tissues; biological materials in the nature of biological preparation for the treatment of eye disease for medical purposes; bioengineered materials in the nature of biological eye tissue; bioengineered biological organ tissues for medicalveterinary and pharmaceutical purposes; biological implants comprising biopolymerscollagennanocelluloseliving tissue for delivery of stem cells and biological agents; implants comprising living tissue; implants comprising biopolymerscollagennanocellulose for guided tissue regeneration; surgical implants biopolymerscollagennanocellulose and native tissuegrown from stem cells; implantable materials in the nature of biopolymerscollagennanocellulosenative tissue for use in guided tissue regeneration; cell culture media for medical purposes for cultivating human and animal cells such as cornealcardiac cells and stem cells

Class 10

Corneal implants in the form of inlays made of artificial and naturalnon-livingmaterials; corneal microlens for sight correction being implants made of artificial and naturalnon-livingmaterials; corneal shields being surgical implants and contact lenses made of artificial and naturalnon-livingmaterials; corneal implants made of artificial and naturalnon-livingmaterials; corneal implants for sight correction made of artificial and naturalnon-livingmaterials; intra-corneal implants made of artificial and naturalnon-livingmaterials; intra-ocular implants made of artificial and naturalnon-livingmaterials; ocular implants made of artificial and naturalnon-livingmaterials; medical implants made of artificial and naturalnon-livingmaterials; biodegradable implants for eyeskinheart applicationsmade of artificial and naturalnon-livingmaterials; prosthetic implants for eyeskinheart applicationsmade of artificial and naturalnon-livingmaterials; artificial implants for eyeskinheart applicationsmade of artificial and naturalnon-livingmaterials for delivery of cellsstem cellsdrugsgenesproteins

Publications

History of USPTO decisions and trademark events.

38 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/07/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/04/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/15/2022

FIMP

FINAL DISPOSITION PROCESSED

03/14/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/28/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

09/28/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/13/2021

PUBO

PUBLISHED FOR OPPOSITION

07/13/2021

GPNX

NOTIFICATION PROCESSED BY IB

07/11/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/23/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

06/23/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/23/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/04/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

06/04/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/04/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

06/04/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/04/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/09/2021

GNFR

FINAL REFUSAL E-MAILED

01/09/2021

CNFR

FINAL REFUSAL WRITTEN

01/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/19/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/18/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/18/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/18/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/18/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/18/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/18/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/18/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/18/2020

RFNT

REFUSAL PROCESSED BY IB

08/01/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/14/2020

RFRR

REFUSAL PROCESSED BY MPU

07/14/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/09/2020

CNRT

NON-FINAL ACTION WRITTEN

06/08/2020

MAFR

APPLICATION FILING RECEIPT MAILED

06/02/2020

DOCK

ASSIGNED TO EXAMINER

05/29/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/29/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/28/2020

Continuous trademark protection

Get notified about every new filing that threatens CORVISION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.